CLARUS THERAPEUTICS HOLDINGS, INC. Increase (Decrease) in Prepaid Expense
CLARUS THERAPEUTICS HOLDINGS, INC. reported Increase (Decrease) in Prepaid Expense of -$476.00 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2022-08-19
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2022-06-30 was -$186.00K.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2022-03-31 was -$290.00K, a 205.45% decline year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2021-12-31 was $782.00K, a 1017.14% increase year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2021-09-30 was $1.91M.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in prepaid expense for fiscal 2021 was $2.83M, a 251.99% increase from fiscal 2020.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in prepaid expense for fiscal 2020 was $804.00K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 3 month as first filed | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 7 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2022-06-30 | -$186.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | -$476.00K 10-Q · filed 2022-08-19 | $306.00K derived: sum of 3 quarters · filed 2022-08-19 | $2.21M derived: sum of 4 quarters · filed 2022-08-19 | |||
| 2022-03-31 | -$290.00K 10-Q · filed 2022-05-16 | $492.00K derived: sum of 2 quarters · filed 2022-05-16 | $2.40M derived: sum of 3 quarters · filed 2022-05-16 | $2.27M derived: sum of 4 quarters · filed 2022-08-19 | |||
| 2021-12-31 | $782.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $2.69M derived: sum of 2 quarters · filed 2022-03-31 | $2.56M derived: sum of 3 quarters · filed 2022-08-19 | $2.83M 10-K · filed 2022-03-31 | |||
| 2021-09-30 | $1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | $1.77M derived: sum of 2 quarters · filed 2022-08-19 | $2.05M 10-Q · filed 2021-11-19 | $2.12M derived: sum of 4 quarters · filed 2022-08-19 | |||
| 2021-06-30 | -$133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | $142.00K 10-Q · filed 2022-08-19 | -$52.72K 10-Q · filed 2021-08-16 | $212.00K derived: sum of 3 quarters · filed 2022-08-19 | |||
| 2021-03-31 | $275.00K 10-Q · filed 2022-05-16 | $16.78K 10-Q · filed 2021-05-26 | $345.00K derived: sum of 2 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $168.14K 10-K · filed 2021-05-06 | $804.00K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $734.00K 10-Q · filed 2021-11-19 |